Phosphorylation of the RNA Polymerase II Carboxyl-Terminal Domain by CDK9 Is Directly Responsible for Human Immunodeficiency Virus Type 1 Tat-Activated Transcriptional Elongation
- 1 July 2002
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 22 (13) , 4622-37
- https://doi.org/10.1128/mcb.22.13.4622-4637.2002
Abstract
Stimulation of transcriptional elongation by the human immunodeficiency virus type 1 Tat protein is mediated by CDK9, a kinase that phosphorylates the RNA polymerase II carboxyl-terminal domain (CTD). In order to obtain direct evidence that this phosphorylation event can alter RNA polymerase processivity, we prepared transcription elongation complexes that were arrested by the lac repressor. The CTD was then dephosphorylated by treatment with protein phosphatase 1. The dephosphorylated transcription complexes were able to resume the transcription elongation when IPTG (isopropyl-beta-D-thiogalactopyranoside) and nucleotides were added to the reaction. Under these chase conditions, efficient rephosphorylation of the CTD was observed in complexes containing the Tat protein but not in transcription complexes prepared in the absence of Tat protein. Immunoblots and kinase assays with synthetic peptides showed that Tat activated CDK9 directly since the enzyme and its cyclin partner, cyclin T1, were present at equivalent levels in transcription complexes prepared in the presence or absence of Tat. Chase experiments with the dephosphorylated elongation transcription complexes were performed in the presence of the CDK9 kinase inhibitor DRB (5,6-dichloro-1-beta-D-ribofuranosyl-benzimidazole). Under these conditions there was no rephosphorylation of the CTD during elongation, and transcription through either a stem-loop terminator or bent DNA arrest sequence was strongly inhibited. In experiments in which the CTD was phosphorylated prior to elongation, the amount of readthrough of the terminator sequences was proportional to the extent of the CTD modification. The change in processivity is due to CTD phosphorylation alone, since even after the removal of Spt5, the second substrate for CDK9, RNA polymerase elongation is enhanced by Tat-activated CDK9 activity. We conclude that phosphorylation of the RNA polymerase II CTD by CDK9 enhances transcription elongation directly.Keywords
This publication has 76 references indexed in Scilit:
- Spt5 Cooperates with Human Immunodeficiency Virus Type 1 Tat by Preventing Premature RNA Release at Terminator SequencesMolecular and Cellular Biology, 2002
- TFIIH Inhibits CDK9 Phosphorylation during Human Immunodeficiency Virus Type 1 TranscriptionJournal of Biological Chemistry, 2001
- TFIIS Enhances Transcriptional Elongation through an Artificial Arrest Site In VivoMolecular and Cellular Biology, 2001
- Characterization of Mediator Complexes from HeLa Cell Nuclear ExtractMolecular and Cellular Biology, 2001
- Positive Transcription Elongation Factor b Phosphorylates hSPT5 and RNA Polymerase II Carboxyl-terminal Domain Independently of Cyclin-dependent Kinase-activating KinaseJournal of Biological Chemistry, 2001
- Conformation of the RNA polymerase II C-terminal domain: circular dichroism of long and short fragmentsJournal of Molecular Biology, 2000
- Direct evidence that HIV-1 tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongationJournal of Molecular Biology, 1999
- Mechanisms of cyclin-dependent kinase regulation: structures of cdks, their cyclin activators, and cip and INK4 inhibitorsJournal of Molecular Biology, 1999
- Role of the human homolog of the yeast transcription factor SPT5 in HIV-1 tat-activationJournal of Molecular Biology, 1998
- Analysis of the signals for transcription termination by purified RNA polymerase IIBiochemistry, 1990